February 2025 Clinical Recap
February 2025 Clinical Recap March 3, 2025 Jake Goll, PharmD (jake.goll@theprismhealthgroup.com) serves as the clinical consultant at Prism Health Group, where he provides end-to-end oversight of clinical strategy through in-depth data analysis, proactive consultation, and subject matter expertise. Gene Therapy: Big Talk, Slow Uptake The Latest on Compounded GLP-1s: FDA Crackdown & Industry […]
March 2025 Clinical Recap
March 2025 Clinical Recap April 5, 2025 Jake Goll, PharmD (jake.goll@theprismhealthgroup.com) serves as the clinical consultant at Prism Health Group, where he provides end-to-end oversight of clinical strategy through in-depth data analysis, proactive consultation, and subject matter expertise. Gene Therapy: Big Talk, Slow Uptake Novo Nordisk Enters the GLP-1 Direct-to-Consumer Space Novo […]
January 2025 Clinical Recap
January 2025 Clinical Recap February 21, 2025 Jake Goll, PharmD (jake.goll@theprismhealthgroup.com) serves as the clinical consultant at Prism Health Group, where he provides end-to-end oversight of clinical strategy through in-depth data analysis, proactive consultation, and subject matter expertise. Gene Therapy: Big Talk, Slow Uptake FTC’s Second Interim Report on PBMs On January 14th, […]